Microcatheters Market Size - By Product, By Design, By Application, By End Use - Global Forecast, 2026-2035

Microcatheters Market Size

The global microcatheters market was valued at USD 1.1 billion in 2025. The market is expected to reach from USD 1.2 billion in 2026 to USD 1.9 billion in 2035, growing at a CAGR of 5.4% during the forecast period, according to the latest report published by Global Market Insights Inc. The high market growth is attributed to the rising prevalence of cardiovascular and neurovascular disorders, advancements in microcatheter technology, and growing preference for minimally invasive surgeries, among other contributing factors.

Microcatheters are thin and supple tubes that are used in minimally invasive surgeries to reach through small or winding blood vessels. They allow accurate delivery of drugs, embolic materials, or devices. The way they are designed helps to get to the vascular areas that are difficult to reach in a safe and efficient manner.
 

The major players in the global microcatheters market are Medtronic, Boston Scientific, Penumbra, Stryker, and TERUMO. These companies maintain their competitive position through ongoing product innovation, global market presence, and substantial investment in research and development.
 

The market has increased from USD 894.1 million in 2022 and reached to USD 1 billion in 2024, with a historic growth rate of 8.4%. The market growth was driven by the growing adoption of interventional radiology, expansion of outpatient surgical centers, and increasing awareness among physicians about advanced microcatheter applications.
 

Moreover, as cases of coronary artery disease, peripheral artery disease, and aneurysms rise, the demand for minimally invasive interventions surges. For instance, according to the American Heart Association, approximately 20.1 million adults aged 20 and older were diagnosed with coronary artery disease in 2022.
 

Additionally, the Centers for Disease Control and Prevention (CDC) reported that peripheral artery disease affects nearly 6.5 million people aged 40 and older in the U.S. In these procedures, microcatheters are vital, adeptly navigating complex vascular networks.
 

Furthermore, continuous innovations such as improved flexibility, steerability, and radiopacity enhance procedural safety and success rates. These technological improvements encourage wider adoption among interventional cardiologists and neurointerventional specialists.

Microcatheters Market Trends

The global market for microcatheters is growing considerably with the miniaturization and enhanced flexibility, integration with imaging and navigation technologies, and expansion into oncology and neurology applications, among other factors collectively driving industry growth.
 

• Manufacturers are focusing on developing smaller, more flexible microcatheters that can navigate complex and tortuous vascular pathways with greater ease. These improvements reduce vessel trauma and expand the range of treatable conditions. Enhanced materials and design features also increase device durability and procedural success. Clinical adoption grows as interventionists gain confidence in performance and outcomes.
   
• There is a strong trend toward combining microcatheters with advanced imaging modalities like intravascular ultrasound (IVUS), optical coherence tomography (OCT), and 3D navigation systems. These integrations help clinicians visualize anatomy in real time, improving precision and reducing procedure times. This convergence of technology is enhancing procedural efficiency and patient safety. As a result, demand for smart, imaging-compatible microcatheters is rising.
   
• Microcatheters initially used in cardiology and peripheral interventions now find use in targeted cancer therapies and interventional neuroradiology. For instance, they are used to administer chemoembolization agents directly into tumors and to maneuver through cerebral vessels to treat aneurysms. By including these expanded therapeutic applications, the clinical use and market scope across specialties are enriched. Success in this research and clinical arena helps increase adoption and sustains market growth.
   

Microcatheters Market Analysis

The global microcatheters industry was valued at USD 894.1 million in 2022. The market size reached USD 1 billion in 2024, from USD 972.9 million in 2023.
 

Based on product, the microcatheters market is segmented into delivery microcatheters, diagnostic microcatheters, steerable microcatheters, and aspiration microcatheters. The delivery microcatheters segment has asserted its dominance in the market by securing a significant market share of 32.4% in 2025 owing to their critical role in precise navigation and targeted delivery of therapeutic agents in complex vascular and neurovascular procedures. The segment is expected to exceed USD 632.3 million by 2035, growing at a CAGR of 5.6% during FFthe forecast period.
 

On the other hand, the aspiration microcatheters segment is expected to grow with a CAGR of 4.6%. The growth of this segment is driven by the increasing adoption of thrombo-aspiration procedures and rising prevalence of stroke and vascular occlusion treatments worldwide.
 

The delivery microcatheters segment continues to dominate the market. Delivery microcatheters are increasingly being used to deliver therapeutic agents directly to specific vascular sites, such as tumors or blocked arteries. This targeted approach improves efficacy while reducing systemic side effects, increasing demand for oncology and cardiovascular treatments. The increasing number of minimally invasive endovascular procedures, including aneurysm embolization and thrombectomy, requires precise delivery systems. Delivery microcatheters enable safe and controlled deployment of devices or drugs, boosting their adoption in hospitals and specialty clinics. The diagnostic microcatheters segment held a revenue of USD 321.2 million in 2025, with projections indicating a steady expansion at a CAGR of 5.1% from 2026 to 2035. The growing demand for accurate vascular imaging and real-time intra-procedural diagnostics is driving the use of diagnostic microcatheters. Furthermore, their ability to improve procedural safety and reduce complications is driving market expansion. The steerable microcatheters segment accounted for significant revenue in 2025 and is anticipated to grow at a CAGR of 5.9% over the forecast period. Increasing need for precise navigation through tortuous vessels and enhanced maneuverability in complex interventions is driving demand for steerable microcatheters. Based on design, the microcatheters market is classified into single lumen microcatheters and dual lumen microcatheters. The dual lumen microcatheters segment dominated the market with a revenue share of 57% in 2025 and is expected to reach USD 1 billion within the forecast period.
 

• Dual lumen microcatheters can deliver devices or fluids while maintaining guidewire access, allowing for precise navigation through tortuous vascular pathways. This increases procedural efficiency and safety, especially for neurovascular and coronary interventions.
   
• They are increasingly used for embolization of aneurysms, arteriovenous malformations, and other neurovascular disorders. The dual lumen design allows for more controlled deployment of coils or liquid emboli, which is why neurointerventional specialists prefer them.
   
• The single lumen microcatheters segment accounted for significant revenue in 2025 and is anticipated to grow at a CAGR of 6.1% over the forecast period. Their straightforward design, ease of use, and dependability in routine interventional procedures are driving widespread adoption. Furthermore, their lower manufacturing and procedural costs make them the preferred choice in high-voluFme clinical environments.
   

Based on application, the microcatheters market is segmented into cardiovascular, neurovascular, oncology, peripheral vascular, and other applications. The cardiovascular segment dominated the market in 2025 accounting for USD 463.4 million and is anticipated to grow at a CAGR of 6% during the forecast period.
 

The rising prevalence of coronary artery disease, peripheral artery disease, and chronic total occlusions is fuelling demand for advanced interventional tools. Microcatheters provide precise access and treatment in complex coronary anatomy, resulting in higher procedural success rates.Further, the rising volume of PCI procedures, including angioplasty and stent placement, is boosting microcatheter usage. These devices assist in guidewire support, lesion crossing, and targeted delivery of contrast or therapeutic agents during interventions.The neurovascular segment accounted for significant revenue in 2025 and is anticipated to grow at a CAGR of 5.6% over the forecast period. The growing use of endovascular therapies for aneurysm and AVM management, along with increasing availability of specialized neurointerventional centers, is driving demand.The oncology segment accounted for significant revenue in 2025 and is anticipated to grow at a CAGR of 4.1% over the forecast period. The growing popularity of catheter-based localized cancer therapies, as well as a preference for targeted drug delivery to reduce systemic side effects, are driving growth.
 

Based on end use, the microcatheters market is classified into hospitals, ambulatory surgical centers, and other end users. The hospitals segment dominated the market with a revenue share of 58.3% in 2025 and is expected to reach USD 1.1 billion within the forecast period.
 

• The high volume of peripheral, neurovascular, and cardiovascular procedures performed in hospitals creates a steady need for microcatheters. Their function as the main hubs for complex and urgent procedures boosts regular use across several departments.
   
• The majority of hospitals have sophisticated imaging systems and catheterization labs needed for microcatheter-based procedures. Adoption of cutting-edge microcatheters for accurate and secure interventions is supported by this infrastructure.
   
• The ambulatory surgical centers segment accounted for significant revenue in 2025 and is anticipated to grow at a CAGR of 5.9% over the forecast period. Increasing shift of interventional procedures toward outpatient settings and faster patient turnaround times are supporting microcatheter adoption in ambulatory surgical centers.
  
   

North America Microcatheters Market

North America dominated the global microcatheters industry with the highest market share of 33.3% in 2025.
 

• The U.S. market for microcatheters was valued at USD 288.4 million and USD 310.6 million in 2022 and 2023, respectively. The market size reached USD 349.8 million in 2025, growing from USD 331.6 million in 2024, and is anticipated to grow at a CAGR of 4.3% from 2026 to 2035.
   
• North America is a leader in the early adoption of complex endovascular procedures like CTO interventions, neurovascular embolization, and structural heart therapies. These procedures necessitate high-performance microcatheters with excellent torque and tracking capabilities. Continuous clinical innovation maintains high procedural volumes. This directly increases the demand for specialized microcatheter solutions.
   
• Moreover, the region is home to a number of global microcatheter innovators and suppliers, facilitating the rapid commercialization of next-generation designs. Close collaboration between clinicians and manufacturers encourages product refinement. Faster regulatory pathways for incremental innovations boost market penetration. This ecosystem generates consistent, technology-driven demand.
   

Europe Microcatheters Market

Europe market accounted for USD 321.8 million in 2025 and is anticipated to show lucrative growth over the forecast period.
 

• European healthcare systems place a high value on procedural safety and long-term results. Microcatheters that allow for precise navigation and controlled delivery are in line with these clinical objectives. Physicians are increasingly favoring devices that minimize contrast use and vessel trauma. This focus addresses the need for high-quality microcatheters.
   
• Furthermore, the region is seeing an increase in treatment rates for peripheral artery disease, particularly among patients with diabetes and the elderly. Microcatheters are used to cross chronic occlusions and administer targeted therapies. The demand is driven by the need for limb-salvage procedures. This broadens the use beyond coronary applications.
   

Asia Pacific Microcatheters Market

The Asia Pacific market is anticipated to grow at the highest CAGR of 6.8% during the analysis timeframe.

• Asia Pacific is experiencing fast growth in catheter-based procedures due to rising disease burden. Hospitals are expanding cath labs and interventional units at a rapid pace. Microcatheters are essential for managing diverse patient anatomies. This expansion drives strong volume-based market growth.
   
• A significant population with undiagnosed cardiovascular and neurovascular conditions is now entering the treatment pathway. Improved diagnostic access is increasing procedural volumes. Microcatheters are increasingly used in first-time interventions. This creates strong demand momentum across emerging economies.
   

Latin America Microcatheters Market

The Latin America market is experiencing robust growth over the analysis timeframe.
 

• Expansion of private hospitals and specialty clinics is improving access to advanced interventions. Microcatheters are increasingly used in urban centers for cardiovascular and neurovascular care. As access improves, procedural demand rises. This supports gradual but steady market growth.
   
• Private healthcare providers are investing in modern interventional infrastructure. Expanded insurance coverage supports affordability of advanced procedures. This encourages hospitals to adopt higher-quality microcatheters. The private sector plays a key role in driving market expansion.
   

Middle East & Africa Microcatheters Market

The Middle East & Africa (MEA) market is experiencing robust growth over the analysis timeframe.
 

• Gulf countries are heavily investing in high-end hospitals and cath labs. These facilities support complex cardiovascular and neurointerventional procedures. Microcatheters are essential tools in these advanced settings. Infrastructure development is a primary growth driver in the region.
   
• Moreover, specialized cardiac and neurovascular centers are being developed to attract regional and international patients. These centers emphasize advanced endovascular care. Microcatheters are critical to delivering high-complexity interventions. This concentration of expertise drives focused demand.
   

Microcatheters Market Share

The global microcatheters industry is moderately consolidated and characterized by strong competition among established global players and specialized manufacturers. Leading companies focus on continuous product innovation, portfolio expansion, and regulatory approvals to strengthen their presence across cardiovascular, neurovascular, and oncology applications. Strategic collaborations, physician training programs, and investments in R&D remain central to maintaining competitive advantage.
 

Key players include Medtronic, Boston Scientific, Penumbra, Stryker, and Terumo, collectively accounting for ~58% of the total market share. Market participants are increasingly emphasizing advanced features such as enhanced trackability, steerability, and compatibility with complex interventional devices. Expansion into emerging markets, coupled with localized manufacturing and distribution strategies, is also shaping competitive dynamics as companies aim to capture untapped demand and improve cost efficiency.
 

Microcatheters Market Companies

Few of the prominent players operating in the microcatheters industry include:

• Abbott
• Acrostak
• ASAHI INTECC USA
• Boston Scientific
• COOK Medical
• Embolx
• Integer Holdings
• Medtronic
• Merit Medical Systems
• Penumbra
• Reflow Medical
• Stryker
• Teleflex
• Terumo
• Transit Scientific
   

· Medtronic

Medtronic’s comprehensive interventional portfolio is supported by strong clinical evidence and physician trust. Its global manufacturing scale and integrated solutions enable consistent quality and wide procedural compatibility.
 

· Boston Scientific

Boston Scientific stands out for its continuous innovation in microcatheter technology, with a focus on precision and reliability in complex interventions. Its strong clinician engagement and training programs enhance adoption and brand loyalty.
 

· Stryker

Stryker’s strong specialization in neurovascular interventions is supported by advanced microcatheters designed for high trackability and control. The company’s focus on outcome-driven technologies strengthens its position in complex stroke and aneurysm procedures.
 

Microcatheters Industry News:

• In December 2025, Bendit Technologies announced that the U.S. Food and Drug Administration (FDA) had granted 510(k) clearance for the Bendit17 Microcatheter, the smallest steerable microcatheter available. This approval marked a key advancement in improving precision and accessibility for neurovascular and peripheral endovascular interventions. The development is expected to strengthen the market by accelerating innovation, expanding clinical adoption of steerable technologies, and intensifying competition among advanced device manufacturers.
   
• In February 2025, Penumbra launched the ACCESS25 Delivery Microcatheter, a single-lumen device developed to support physician access to the neurovasculature for delivery of its 0.02 coil platform. The microcatheter is compatible with MIDWAY Intermediate catheters and BENCHMARK/BMX guide catheters, offering improved trackability and stable support during neurovascular embolization procedures. This launch strengthened the microcatheters market by expanding delivery-focused product offerings, improving procedural efficiency, and reinforcing demand for application-specific neurovascular microcatheters.
   
• In February 2024, BIOTRONIK introduced the Micro Rx catheter, a novel rapid exchange microcatheter designed to enhance guidewire support during percutaneous coronary interventions (PCI). The device featured a reinforced distal shaft with a core wire between braided layers and a tapered tip with one of the smallest leading edges for improved penetration. This launch supported the market by advancing PCI-specific device performance, improving procedural success rates, and driving adoption in complex coronary interventions.
   

The microcatheters market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2022 – 2035 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Delivery microcatheters
• Diagnostic microcatheters
• Steerable microcatheters
• Aspiration microcatheters

Market, By Design

• Single lumen microcatheters
• Dual lumen microcatheters

Market, By Application

• Cardiovascular
• Neurovascular
• Oncology
• Peripheral vascular
• Other applications

Market, By End Use

• Hospitals
• Ambulatory surgical centers
• Other end users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE